Check if your research matches the topics covered in Expert Review of Anticancer Therapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University Medical Center Amsterdam. According to Journal Citation Reports, the journal has a 2019 impact factor of 3.573. Less
Overview | |
Publisher | TAYLOR & FRANCIS LTD |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 2000 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
Expert Review of Anticancer Therapy has been in operation since 2000 till date.
Expert Review of Anticancer Therapy published with a Monthly frequency.
In 2023, Expert Review of Anticancer Therapy publsihed 119 articles.
For Expert Review of Anticancer Therapy, eISSN is 1744-8328 and pISSN is 1473-7140.
Citescore for Expert Review of Anticancer Therapy is 6.7.
H Index for Expert Review of Anticancer Therapy is 79.
SNIP score for Expert Review of Anticancer Therapy is 1.08.
SJR for Expert Review of Anticancer Therapy is Q2.
TAYLOR & FRANCIS LTD is the publisher of Expert Review of Anticancer Therapy.